Cefdinir Side Effects
Some side effects of cefdinir may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to cefdinir: oral capsule, oral powder for suspension
Along with its needed effects, cefdinir may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking cefdinir:More common
- Black, tarry stools
- chest pain
- painful or difficult urination
- shortness of breath
- sore throat
- sores, ulcers, or white spots on the lips or in the mouth
- swollen glands
- unusual bleeding or bruising
- unusual tiredness or weakness
- Abdominal or stomach cramps or tenderness
- back, leg, or stomach pains
- bleeding gums
- blistering, peeling, or loosening of the skin
- blood in the urine or stools
- bloody nose
- bloody or cloudy urine
- bloody, black, or tarry stools
- blue lips, fingernails, or skin
- chest pain or discomfort
- clay-colored stools
- cold, clammy skin
- coughing or vomiting blood
- cracks in the skin
- dark-colored urine
- diarrhea, watery and severe, which may also be bloody
- difficult or troubled breathing
- difficulty with breathing or swallowing
- dilated neck veins
- extreme fatigue
- fast heartbeat
- fast, weak pulse
- feeling of discomfort
- general body swelling
- general tiredness and weakness
- heavier menstrual periods
- high fever
- increased thirst
- inflammation of the joints
- irregular breathing
- irregular heartbeat
- irregular, fast or slow, or shallow breathing
- joint or muscle pain
- light-colored stools
- loss of appetite
- loss of consciousness
- loss of heat from the body
- muscle aches
- muscle cramps or spasms
- muscle pain or stiffness
- nausea or vomiting
- noisy breathing
- pain in the ankles or knees
- pain or discomfort in the arms, jaw, back, or neck
- painful, red lumps under the skin, mostly on the legs
- pale skin
- persistent bleeding or oozing from puncture sites, mouth, or nose
- pinpoint red spots on the skin
- problems with bleeding or clotting
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- red skin lesions, often with a purple center
- red, irritated eyes
- red, swollen skin
- scaly skin
- severe stomach pain
- slow or irregular breathing
- sudden decrease in the amount of urine
- swelling of the face, fingers, feet, or lower legs
- swollen lymph glands
- tightness in the chest
- unpleasant breath odor
- unusual weight loss
- upper right abdominal or stomach pain
- vomiting of blood
- weight gain
- yellow eyes or skin
Some side effects of cefdinir may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:Less common
- Itching of the vagina or genital area
- pain during sexual intercourse
- thick, white vaginal discharge with no odor or with a mild odor
- vaginal yeast infection
- Acid or sour stomach
- dry mouth
- excess air or gas in the stomach or intestines
- full feeling
- increase in body movements
- increased clear or white vaginal discharge
- lack or loss of strength
- passing gas
- rash with flat lesions or small raised lesions on the skin
- sleepiness or unusual drowsiness
- soreness or redness around the fingernails and toenails
- stomach discomfort, upset, or pain
- unable to sleep
- Burning, dry, or itching eyes
- discharge, excessive tearing
- redness, pain, or swelling of the eye, eyelid, or inner lining of the eyelid
- swelling or inflammation of the mouth
For Healthcare Professionals
Applies to cefdinir: oral capsule, oral powder for reconstitution
Reddish-colored stools have occurred when cefdinir was taken with iron-containing products, and may be due to the formation of non-absorbable complexes in the GI tract.
Gastrointestinal side effects have included diarrhea (15%), nausea (3%), abdominal pain (1%), dyspepsia (0.7%), flatulence (0.7%), vomiting (0.7%), anorexia (0.3%), constipation (0.3%), dry mouth (03%), abnormal stools (0.3%), moniliasis (0.2%) and pseudomembranous colitis. Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included stomatitis, acute enterocolitis, bloody diarrhea, hemorrhagic colitis, melena, upper GI bleed, peptic ulcer, and ileus.
Hypersensitivity reactions associated with cephalosporin class antibiotics have included allergic reactions, anaphylaxis, Stevens-Johnson syndrome, erythema multiforme, and toxic epidermal necrolysis. Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included anaphylaxis (with rare cases of fatality), serum sickness-like reactions, Stevens-Johnson syndrome, and toxic epidermal necrolysis.
Dermatologic side effects have included rash (0.9%) and pruritus (0.2%). Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included exfoliative dermatitis, erythema multiforme, and erythema nodosum.
Genitourinary side effects have included vaginal moniliasis (4% of women), vaginitis (1% of women), leukorrhea (0.2% of women), increased urine leukocytes (2%), increased urine protein (1%), increased microhematuria (1%), increased urine glucose (0.9%), increased urine specific gravity (0.6%), decreased urine specific gravity (0.2%), increased urine pH (0.2%). Cephalosporins as a class have been associated with false-positive tests for urine glucose.
Nervous system side effects have included headache (2%), dizziness (0.3%), insomnia (0.2%), asthenia (0.2%), and somnolence (0.2%). Some cephalosporins have been associated with seizures in renally impaired patients. Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included loss of consciousness.
Hematologic side effects have included increased lymphocytes (1%), decreased lymphocytes (0.2%), increased white blood cells (0.9%), decreased white blood cells (0.7%), increased eosinophils (0.7%), decreased hemoglobin (0.3%), increased polymorphonuclear neutrophils (0.3%), decreased polymorphonuclear neutrophils (0.2%), and increased platelets (0.2%). Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included granulocytopenia, pancytopenia, leukopenia, thrombocytopenia, idiopathic thrombocytopenic purpura, hemolytic anemia, bleeding tendency, coagulation disorder, and disseminated intravascular coagulation. Cephalosporins as a class have been associated with aplastic anemia, hemolytic anemia, prolonged prothrombin time, hemorrhage, neutropenia, pancytopenia, and agranulocytosis.
Metabolic side effects have included increased gamma-glutamyltransferase (1%), increased alanine aminotransferase (0.7%), decreased bicarbonate (0.6%), increased phosphorus (0.6%), decreased phosphorus (0.3%), increased aspartate aminotransferase (0.4%), increased alkaline phosphatase (0.3%), increased blood urea nitrogen (0.3%), increased bilirubin (0.2%), increased lactate dehydrogenase (0.2%), and increased potassium (0.2%).
Hepatic side effects associated with cephalosporins as a class have included hepatic dysfunction, including cholestasis. Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included acute hepatitis, cholestasis, fulminant hepatitis, hepatic failure, jaundice, and increased amylase.
Renal side effects associated with cephalosporins as a class have included renal dysfunction and toxic nephropathy. Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included acute renal failure and nephropathy.
Ocular adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included conjunctivitis.
Respiratory adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included acute respiratory failure, asthmatic attack, drug-induced pneumonia, eosinophilic pneumonia, and idiopathic interstitial pneumonia.
Adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included fever, shock, feeling of suffocation, and facial and laryngeal edema.
Cardiovascular adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included cardiac failure, chest pain, myocardial infarction, hypertension, and allergic vasculitis.
Musculoskeletal adverse effects reported during postmarketing experience with cefdinir, regardless of causality, have included involuntary movements and rhabdomyolysis.
Geriatric patients have been reported to experience a lower rate of adverse events, including diarrhea, than younger patients.
More cefdinir resources
- cefdinir Advanced Consumer (Micromedex) - Includes Dosage Information
- cefdinir MedFacts Consumer Leaflet (Wolters Kluwer)
- Cefdinir Prescribing Information (FDA)
- Cefdinir Professional Patient Advice (Wolters Kluwer)
- Cefdinir Monograph (AHFS DI)
- Omnicef Prescribing Information (FDA)
- Omnicef Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.